CellaVision AB
STO:CEVI
CellaVision AB
Total Liabilities
CellaVision AB
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CellaVision AB
STO:CEVI
|
Total Liabilities
kr196.2m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
14%
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Total Liabilities
kr20.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Total Liabilities
kr651m
|
CAGR 3-Years
18%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
|
Getinge AB
STO:GETI B
|
Total Liabilities
kr30.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Total Liabilities
kr7.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
S
|
Stille AB
STO:STIL
|
Total Liabilities
kr301.7m
|
CAGR 3-Years
23%
|
CAGR 5-Years
38%
|
CAGR 10-Years
33%
|
|
CellaVision AB
Glance View
CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
See Also
What is CellaVision AB's Total Liabilities?
Total Liabilities
196.2m
SEK
Based on the financial report for Dec 31, 2024, CellaVision AB's Total Liabilities amounts to 196.2m SEK.
What is CellaVision AB's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
14%
Over the last year, the Total Liabilities growth was -8%. The average annual Total Liabilities growth rates for CellaVision AB have been -11% over the past three years , -8% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet